Abstract. The purpose of this study was to investigate relationships between patient attributes and organ dose for a population of computational phantoms for 20 tomosynthesis and radiography protocols. Organ dose was estimated from 54 adult computational phantoms (age: 18 to 78 years, weight 52 to 117 kg) using a validated Monte-Carlo simulation (PENELOPE) of a system capable of performing tomosynthesis and radiography. The geometry and field of view for each exam were modeled to match clinical protocols. For each protocol, the energy deposited in each organ was estimated by the simulations, converted to dose units, and then normalized by exposure in air. Dose to radiosensitive organs was studied as a function of average patient thickness in the region of interest and as a function of body mass index. For tomosynthesis, organ doses were also studied as a function of x-ray tube position. This work developed comprehensive information for organ dose dependencies across a range of tomosynthesis and radiography protocols. The results showed a protocol-dependent exponential decrease with an increasing patient size. There was a variability in organ dose across the patient population, which should be incorporated in the metrology of organ dose. The results can be used to prospectively and retrospectively estimate organ dose for tomosynthesis and radiography.
Introduction
Radiography and tomosynthesis are two imaging modalities that utilize ionizing radiation. Radiography generates twodimensional images of the region of interest for a few discrete positions of the x-ray tube and is useful for imaging patients at a low cost and with low radiation dose. 1 In tomosynthesis, multiple projections of the region of interest are acquired over a predetermined sweep of the x-ray tube, which can then be reconstructed to generate semi-three-dimensional (3-D) images. 2, 3 Tomosynthesis has been developed as an imaging modality that delivers a smaller radiation dose than computed tomography (CT) while still providing 3-D type of information, analogous, but not identical to, CT. 2, 3 While tomosynthesis and radiography procedures are both beneficial to patients when medically justified, it is important to know the radiation risk associated with these imaging modalities. 4 Radiation risk in the clinic is currently assessed by surrogates, such as dose area product and exposure in air. 5 While such surrogates are useful for making comparisons between tube output for different protocols of the same imaging modality and the same patient, they do not fully reflect the radiation burden to the patient, best characterized in terms of organ dose. Alternatively, effective dose has been used to characterize patient burden. However, effective dose has two key limitations: (a) It is a metric based upon a specific reference phantom and cannot be applied to individual patients; 6, 7 (b) it describes the overall radiation burden using a single number 7, 8 that does not convey the individual dose dependencies for specific radiosensitive organs. Currently in the clinic, patient specific radiation doses are unavailable. To assess radiation risk to specific patients, Monte-Carlo (MC) simulations can be utilized to estimate organ dose in a wide range of body sizes. Sabol et al. 9 and Båth et al. 10 used Monte-Carlo methods to estimate dose in chest tomosynthesis and radiography for a single generic phantom. It can be argued that a single patient model cannot represent a population. In fact, others have demonstrated the effect by using Monte-Carlo simulations to estimate organ dose across a population of phantoms for CT protocols. [11] [12] [13] Sahbaee et al. 12 created a patient specific organ dose estimator for 13 CT protocols across a range of 58 anatomically variable adult computational phantoms. From the study, relationships between organ dose and patient size were derived and incorporated into an iPhone application called XCATdose that estimates patient organ dose from CT scans based upon the patient size and scanning parameters. 12 Zhang et al. 13 studied patient-specific radiation dose for chest CT, tomosynthesis, and radiography protocols across the same phantom population, similarly showing organ dose dependencies and variabilities as a function of patient size. These studies illustrate the feasibility of estimating organ dose for a population of patients in tomosynthesis and radiography; however, they do not cover a wide range of protocol estimation.
The purpose of this study, which is built upon prior efforts, was to provide organ dose estimation for an expanded set of Thoracic spine LAT Table  100 23 85 radiography and tomosynthesis protocols. In this study, a Monte-Carlo software was used to simulate dose to voxelized human models from a clinical x-ray system. The purpose of this work was to investigate relationships between patient attributes and organ doses and, in doing so, provide coefficients that can be used to prospectively or retrospectively estimate organ dose in tomosynthesis and radiography.
Methods

Human Models
A population of adult computational XCAT human models 14 was used in the study to serve as a library of virtual patients for the MC simulations. The models provide realistic models of 54 anatomically variable patients (22 females, 32 males, ages from 18 to 78 years, and weights from 52 to 117 kg) to represent a clinical population. The phantoms are defined using nonuniform rational B-spline surfaces, which allow the flexibility to manipulate their positioning. The arms were repositioned to have a posture with either the arms up or down depending on the given exam protocol. For this study, the XCAT models were voxelized with a 3.45-mm isotropic resolution.
Protocols
The clinical x-ray modeled in this study was a typical projection x-ray system, the GE Definium 8000, GE Healthcare, Chalfont St Giles, UK. This system is a radiographic unit that can also perform tomosynthesis exams with appropriate software.
Simulations for a range of typical for radiography and tomosynthesis protocols included head, cervical spine, thoracic spine, chest, lumbar spine, abdomen, hip, and knee. Radiography protocol geometries including the source-to-image distance (SID), and peak kilo-voltage (kVp) were modeled to match the institutional technique chart used clinically for imaging patients on this system (Table 1) . Tomosynthesis protocol parameters including pivot point, number of projection views, and sweep range were acquired from a list of 20 technique protocols provided by the manufacturer and the institutional technique charts ( Table 2 ). The kVp for each patient was chosen by calculating the average thickness of the computational phantom in the region of the body being scanned. For AP/PA and lateral exams, the thickness was calculated in the AP direction and lateral direction, respectively. The kVp was determined by matching the phantom thickness to the closest thickness value on the institutional technique chart ( Table 1) . The x-ray spectra for each kVp were generated using the TASMICS method developed by Hernandez and Boone. 15 
Tomosynthesis Geometry
The tomosynthesis exam geometry was set up independently for each projection. The total sweep angle (2θ) was used to calculate the extreme tube position locations as the tube rotates about a pivot point (Fig. 1 ). The tube position increment was then calculated by dividing the distance between the extreme tube positions by the number of projection images to ensure a constant step size that mimics clinical protocols. The field of view (FOV) for each exam was calculated to include relevant organs based on imaging protocol and position of the organs of interest. In each case, the FOV included an added 3 cm margin superiorly and inferiorly to mimic margins used in a clinical setting to ensure complete anatomy coverage ( Table 3 ). The collimation was determined at first by calculating the field size at the detector for the center tube position. For the tomosynthesis exams, the beam was collimated as a function of angle to ensure (a) the anatomy of interest was within the FOV and (b) the x-rays would not exceed the detector FOV. The positioning of the phantom patient anatomy for each protocol was based on standard positioning guidelines. 16, 17 
Organ Dose Simulation
Organ dose estimation was performed using 8 × 10 7 histories and a previously validated PENELOPE Monte-Carlo simulation package. 18 The number of photon histories was chosen to ensure organ dose errors of less than 5% for organs in the FOV. 12 Subsequently, the energy deposited in each organ was calculated and normalized by the number of starting photons. Then, the organ doses were calculated and normalized by a dose in air: this was done by calculating n, the number of photons per mm 2 per mR at 100 cm from the source for a given kVp. The value of n (photons∕mm 2 ∕mR) was calculated for each x-ray spectra.
With d (mGy/photon) as the organ dose normalized by the number of starting photons, the organ dose normalized by exposure D (mGy/mR) was calculated as E Q -T A R G E T ; t e m p : i n t r a l i n k -; s e c 2 . 4 ; 3 2 6 ; 5 3 5
This resulted in organ doses normalized by exposure in air at 100 cm, which can be used to calculate absolute organ doses when multiplied by exposure in air for varying tube currents.
Analysis
In total, organ doses were computed for all 54 adult patients in our library of computational phantoms across 20 different tomosynthesis and radiography protocols. Organ doses were analyzed as a function of patient body mass index (BMI) and average patient thickness for each tomosynthesis and radiography exam. Tables of fitting parameters and goodness of fit measures were generated for each exam protocol. For each protocol, the average thickness calculated was the average thickness in the FOV for the exam along the relevant AP/PA or lateral direction. The AP/PA and lateral protocols were analyzed as a function of corresponding thickness. Dose to a given organ was also studied for tomosynthesis across all angles of a protocol to evaluate how projection angle affects dose to a particular organ. Fig. 1 A schematic drawing of the tomosynthesis acquisition geometry for a total sweep angle of 2θ. Negative angles mean that the x-ray tube is inferior to the pivot point. 3 Results
Organ Dose in Tomosynthesis
In general, organ dose was found to exponentially decrease with an increase in patient BMI and average patient thickness for tomosynthesis body protocols including cervical spine, thoracic spine, lumbar spine, abdomen, chest, and hip. Tables were created for each protocol to display fitting parameters for an exponential decrease relationship with BMI and thickness with associated R 2 and root-mean-square error (RMSE) ( Table 4) . The fitting parameter a indicates the magnitude of the organ doses, with small and large values indicating small and large organ dose, respectively. The fitting parameter b indicates how quickly the dose changes as the patient size increases. The R 2 and RMSE parameters indicate the quality of the exponential fit with R 2 closer to 1 and RMSE closer to 0 indicating an exponential fit that better characterizes variability in the data. While there were many organs with R 2 greater than 0.4, there were few organs with R 2 above 0.9, indicating that the exponential decrease relationship with patient size can only partially explain variations in patient dose across this population. In general, organs that were closer to the FOV for the exam were more likely to have higher R 2 and lower RMSE values. For a complete list of all fitting tables for tomosynthesis, see Tables 6  to 23 in Appendix A. For a given organ, sometimes thickness was a better descriptor of organ dose variation and other times BMI was a better descriptor of organ dose variation. For the AP abdomen tomosynthesis exam (Table 4) , a greater percentage of the BMI coefficients had an R 2 greater than 0.4 compared with thickness coefficients. However, even though the BMI coefficients had a greater proportion of high R 2 values, the magnitude of the R 2 values was not always higher for BMI coefficients. For example, bladder, large intestine, and pancreas all had higher BMI R 2 values, but marrow, bone, ovaries, uterus, and vagina all had higher thickness R 2 values. In the case of bone and marrow, the R 2 parameter was much greater for thickness than for BMI (Fig. 1) . The coefficients used to estimate organ dose should be chosen based on which coefficient gives the minimum error in the estimate.
For some exam protocols, BMI is not a great descriptor of patient variation because these regions do not vary significantly as a function of changing BMI. For instance, the head and knee protocols showed few exponential decrease trends relating BMI with organ dose. These exams demonstrate the variability in organ dose across a population that is not attributable to patient size. For the AP knee tomosynthesis protocol, the mean bone dose across all 54 patient models was 0.069 mGy∕mR with standard deviation of 0.0055 mGy∕mR. For a lateral skull exam, the mean brain dose across the models was 0.36 mGy∕mR with a standard deviation 0.017 mGy∕mR.
Organ dose can also be studied as a function of tomosynthesis tube position. Organ dose from an AP chest tomosynthesis protocol plotted in Fig. 2 shows the average dose as a function of the tube position for different organs in or near the FOV. The organ dose value is averaged for a given tube position across all models in the study. This figure shows that on average, the liver and stomach dose increase as the x-ray tube moves from the cranial to caudal ends of the body. However, organs such as lung, breast, and heart that are directly in the FOV for all projections show a slight parabolic or constant dose as a function of tube position.
Organ dose can also be used to compare organ dose across two different protocols for imaging the same organ. For example, organ dose for an AP thoracic spine tomosynthesis protocol can be compared with dose from a lateral thoracic spine tomosynthesis protocol as a function of tube position (Fig. 3) . The AP thoracic spine protocol resulted in higher organ doses to these specific organs than the lateral protocol (Fig. 4) . In both protocols, the liver dose increased as the x-ray tube moved toward the feet; however, the percent increase was greater for the lateral protocol than the AP protocol by factors of 9.4× and 1.7×, respectively.
Radiography Organ Dose
Noticeable trends were found in organ dose as a function of BMI and patient AP thickness for cervical spine, thoracic spine, lumbar spine, abdomen, and hip protocols. Table 5 shows one example of fitting parameter results and goodness of fit measures for an AP abdomen radiography protocol. For a complete list of all fitting tables for radiography, see Tables 24 to 42 in Appendix B. Radiography exponential decrease trends with thickness and BMI were comparable to tomosynthesis trends. The thickness and BMI coefficients each had 12 organs with R 2 values greater than 0.4, which means that, in general, the BMI coefficients and the thickness coefficients are both equally good predictors of organ dose. The radiography coefficients for this exam are different from the tomosynthesis coefficients because they are generally higher R 2 values and lower RMSE values than their corresponding tomosynthesis exam. However, the radiography coefficients and tomosynthesis coefficients are similar in that they show that the same organs near the FOV have higher R 2 values than organs further away. Like tomosynthesis, in radiograph, some cases had thickness coefficients with less fitting error, and in other cases, the BMI coefficients had less error. For example, the bone and marrow doses showed a similar trend to tomosynthesis, except the R 2 values were larger for radiography BMI than for tomosynthesis BMI (Fig. 5 ).
Discussion
This study demonstrates organ dose estimation for different body organs using both patient BMI and the average patient thickness in the exam region. For some organs, exponential decrease relationships with patient thickness better described organ dose variation. In other cases, exponential decrease relationships with patient BMI better described organ dose variation. In general, the variation in dose can only be partially described by either of these exponential decrease relationships. The coefficients generated based on this population of patients can be used to estimate dose to patients with smaller error bars than prior studies that use one generic phantom alone. However, the variability in the results also indicates a need to develop a future framework for estimating organ dose for specific patients.
Our results are generally consistent with prior reports. The results show trends with an exponential decrease in size, similar to those in Zhang et al. 13 for chest radiography and tomosynthesis protocols. Zhang et al. 13 found an exponential decrease of correlations with increasing patient size with R 2 values ranging from 0 to 0.62 for lung, breast, and liver dose normalized by mAs. Similar R 2 magnitudes were found in this study for exponential decrease relationships as a function of patient size for radiography and tomosynthesis protocols. Our lung dose for an AP chest radiography protocol was comparable to that from previous dose estimates in lung, bone marrow, and thyroid for a male reference phantom. 19 After a unit conversion, the average male lung dose from the previous work was 0.0026 mGy∕mR compared with an average male lung dose of 0.0027 mGy∕mR in this study. The bone marrow dose for the prior study was 0.00083 mGy∕mR compared with 0.00087 mGy∕mR for this study. The thyroid dose for the prior study was 0.00032 mGy∕mR compared with 0.00064 mGy∕mR for this study. We attribute the difference in thyroid dose to differences in collimation decisions made between the two studies. In summary, the organ doses common to both studies had the same order of magnitude.
Our results show that for most cases either patient BMI or thickness can be used to estimate patient specific organ doses. Patient BMI is easier to calculate because it does not require measuring the average patient thickness in the region of the body being exposed. Patient height and weight used to calculate BMI are commonly reported in medical records. The patient BMI can be calculated before the onset of the exam, and this could give providers an estimate of organ dose prior to exposing the patient. However, in many cases, trends as a function of patient thickness resulted in stronger exponential correlation with organ dose. Making an estimate of average thickness can be cumbersome and inaccurate. One possibility for avoiding multiple measurements is to use the thickness measure from the orthogonal image series if multiple views are acquired for a patient.
Organ dose was chosen as the relevant metric in this study for three reasons. First, organ dose is a patient-specific metric of dose that directly quantifies the radiation burden to the patient. The granularity of organ dose highlights how one protocol results in different absorbed doses to different organs and to different patients. Second, organ dose is the best metric to approach cancer risk to radiosensitive organs. Stochastic effects such as cancers originate within the organ, so the only way to determine a relationship between cancer risk in each organ and radiation exposure is to know what dose was delivered to the organ. Deterministic effects are also described by the organ in which they originate, which leads to the third reason, which is that cumulative deterministic effects, such as erythema and epilation, are also best described and predicted on the organ level.
One limitation of this study was that the simulations cannot be applied to specific patients as organs are not always in the exact same place from patient to patient. Different distributions and relative sizes of organs can cause variations in organ dose. The results, however, can be used to inform more accurate size specific patient organ doses with better precision than prior studies that estimate organ dose for one or two reference phantoms alone. Additionally, the simulations in this study relied on protocols from one manufacturer. If another scanner was modeled, organ doses to patients would be different. However, we believe that the normalization of the organ dose by exposure in air allows one to somewhat generalize our organ dose estimates if a similar geometry is used. Prior studies have found that normalizing organ doses from CT scans by the CT dose index (CTDI vol ) makes them generalizable to different CT scanners. 11, 12, 20 In a similar manner, normalization by exposure in air makes our results more generalizable to protocols with similar geometry and less susceptible to slight differences in kVp and filtration.
The scope of this study was to estimate radiation dose from clinically relevant protocols. The protocols in this study were modeled from the institutional technique charts, which were designed to optimize image quality compared with dose at the detector for radiography. The tomosynthesis geometry was provided by the manufacturer, but the kVp values were not necessarily optimized for tomosynthesis image quality. A future trial would be necessary to optimize the protocols at the patient level based on calculated organ dose values in combination with image quality outcomes.
There are at least three ways that estimated organ doses reported in this study can be used by clinicians and researchers. The first way is to use organ dose to directly compare different ionizing imaging modalities. It is not possible to directly compare dose area product, peak skin dose, exposure in air, CTDI vol , etc., for each different modality because these metrics are not the same. Organ dose can easily be compared across modalities because it is the same metric regardless of modality. The second use of patient-specific organ estimation is as a metric for monitoring radiation delivered to a patient across the healthcare enterprise. Monitoring of radiation dose can be used to compare with national averages and to ensure compliance with imaging best practices. 21 Monitoring also allows for more targeted prospective planning and management of cumulative radiation dose in certain at risk groups of patients. 21 Organ dose is the best metric for monitoring dose at a patient specific level because it is the metric that allows for easiest direct knowledge of radiation burden for a given patient that is consistent across protocols. The third use of organ dose is to describe patient risk in human subject studies that use ionizing imaging. All human subject studies require informed consent about the risks associated with the study. 22 A report of organ dose is the most direct way to quantify radiation risk for a patient in a consistent way across protocols.
Conclusion
This study demonstrated patient specific organ dose across a wide range of tomosynthesis and radiography protocols as well as anatomies. The results of this study can be used in various research and clinical applications. The organ doses coefficients reported can be used to compare dose across multiple modalities, to monitor radiation dose at a hospital, to give informed consent in human subject studies, and can be used to calculate a whole-body risk estimate. Results from this study may be used in a software application to calculate patientspecific organ dose in radiography and tomosynthesis.
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